Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.2900
+0.0100 (3.57%)
At close: Nov 17, 2026

BOM:531752 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
-----24.74
Other Revenue
12.4819.5911.987.892.50.07
12.4819.5911.987.892.524.81
Revenue Growth
-63.05%63.57%51.78%215.26%-89.91%52.90%
Cost of Revenue
-----20.15
Gross Profit
12.4819.5911.987.892.54.66
Selling, General & Admin
2.052.831.680.841.750.54
Other Operating Expenses
10.613.199.43.672.721.08
Operating Expenses
12.6516.0111.084.514.461.62
Operating Income
-0.173.580.893.38-1.963.04
Other Non Operating Income (Expenses)
-0----
EBT Excluding Unusual Items
-0.173.580.893.38-1.963.04
Gain (Loss) on Sale of Investments
---3.59---3.12
Gain (Loss) on Sale of Assets
5.995.99-15.926.63-
Pretax Income
5.829.57-2.719.314.67-0.09
Income Tax Expense
0.970.970.23-0.11-
Net Income
4.858.6-2.9319.314.56-0.09
Net Income to Common
4.858.6-2.9319.314.56-0.09
Net Income Growth
-71.75%--323.86%--
Shares Outstanding (Basic)
-903761761761761
Shares Outstanding (Diluted)
-903761761761761
Shares Change
-18.55%----
EPS (Basic)
-0.01-0.000.030.01-0.00
EPS (Diluted)
-0.01-0.000.030.01-0.00
EPS Growth
---323.91%--

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%18.79%
Operating Margin
-1.34%18.26%7.46%42.87%-78.19%12.24%
Profit Margin
38.86%43.87%-24.44%244.67%181.98%-0.35%
EBIT
-0.173.580.893.38-1.963.04
EBIT Margin
-1.34%18.26%7.46%42.87%-78.19%12.24%
Effective Tax Rate
16.71%10.17%--2.42%-
Revenue as Reported
18.4725.5811.9823.829.1324.81